Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Catriona Buick"'
Autor:
Saeed Moradian, Shive Ghasemi, Babak Boutorabi, Zakieh Sharifian, Fay Dastjerdi, Catriona Buick, Charlotte T. Lee, Samantha J Mayo, Plinio P. Morita, Doris Howell
Publikováno v:
Cancer Informatics, Vol 22 (2023)
Introduction: Immunotherapy has revolutionized the treatment of many different types of cancer, but it is associated with a myriad of immune-related adverse events (irAEs). Patient-reported outcome (PRO) measures have been identified as valuable tool
Externí odkaz:
https://doaj.org/article/08ef58bdf28a4350ba20b2048a5ab33a
Publikováno v:
BMC Women's Health, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background With the introduction of oncogenic Human Papillomavirus (HPV) testing into cervical screening there is a renewed focus on primary prevention among high-risk groups. To date, little is known about the effectiveness of this program,
Externí odkaz:
https://doaj.org/article/8dcc6c862880421890edff5bf9652ff6
Autor:
Catriona Buick, Kelly Metcalfe
Publikováno v:
Canadian Oncology Nursing Journal, Vol 19, Iss 2, Pp 60-64 (2009)
In Canada, approximately 1,500 women are diagnosed with cervical cancer every year, and 581 will die of the disease (WHO/ICO Information Centre on HPV and Cervical Cancer, 2007). The importance of preventing cervical cancer is clear, as the effects t
Externí odkaz:
https://doaj.org/article/00b40cd15ec241be84a5b536e0bd764e
Autor:
Catriona Buick, Kelly Metcalfe
Publikováno v:
Canadian Oncology Nursing Journal, Vol 19, Iss 2, Pp 1-5 (2009)
Tous les ans, environ 1500 Canadiennes sont diagnostiquées du cancer du col de l’utérus et 581 d’entre elles mourront de la maladie (WHO/ICO Information Centre on HPV and Cervical Cancer (2007). La prévention du cancer du col de l’utérus es
Externí odkaz:
https://doaj.org/article/e8d032fe757f45d2b6b5cbf0c7501c69
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 42:1518-1524
Objectives In 2012, Ontario's cervical cancer screening program changed the age of initial screening from 18 years of age to 21 and identified women aged 21–24 years as a special population whose cervical squamous intraepithelial lesions should be
Publikováno v:
BMC Women's Health
BMC Women's Health, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Women's Health, Vol 21, Iss 1, Pp 1-9 (2021)
Background With the introduction of oncogenic Human Papillomavirus (HPV) testing into cervical screening there is a renewed focus on primary prevention among high-risk groups. To date, little is known about the effectiveness of this program, and the
Publikováno v:
Journal of immigrant and minority health. 21(6)
Approximately 30–40 million undocumented immigrants worldwide suffer restricted health care. A scoping review was conducted to determine what is known about this population’s palliative end-of-life care experiences. The scoping review followed Ar
Autor:
Kelly Metcalfe, Catriona Buick
Publikováno v:
Canadian Oncology Nursing Journal, Vol 19, Iss 2, Pp 60-64 (2009)
In Canada, approximately 1,500 women are diagnosed with cervical cancer every year, and 581 will die of the disease (WHO/ICO Information Centre on HPV and Cervical Cancer, 2007). The importance of preventing cervical cancer is clear, as the effects t
Autor:
Kelly Metcalfe, Catriona Buick
Publikováno v:
Canadian Oncology Nursing Journal, Vol 19, Iss 2, Pp 1-5 (2009)
Tous les ans, environ 1500 Canadiennes sont diagnostiquées du cancer du col de l’utérus et 581 d’entre elles mourront de la maladie (WHO/ICO Information Centre on HPV and Cervical Cancer (2007). La prévention du cancer du col de l’utérus es